| abstract |
The invention provides a cDNA which encodes a human prostate-associated protease differentially expressed in prostate cancer. It also provides for the use of the cDNA, fragments, complements, and variants thereof and of the encoded protein, portions thereof and antibodies thereto for diagnosis and treatment of prostate cancer. The invention additionally provides expression vectors and host cells for the production of the protein and a transgenic model system. |